Merck plans to sell its allergy business unit to cut debt: Bloomberg

(Reuters) - German drugs and chemicals maker Merck KGaA is planning to sell its allergy business, Allergopharma, Bloomberg reported, citing sources.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.